Pfizer COVID booster events for eligible faculty and staff
COVID-19 Response and Recovery Task Force
To: Faculty and Staff
Dear Colleagues:
COVID-19 Pfizer-BioNTech booster vaccine events are available to eligible employees starting this Friday, Oct. 15 through Sunday, Oct. 31.
UCLA employees who meet the eligibility requirements and have received the second of the two-dose Pfizer vaccine at least six months ago are eligible for the booster.
- Locations and times: The events will take place daily, Oct. 15 – 31, from 6:30 a.m. – 10:30 p.m. at Ronald Reagan UCLA Medical Center in the B-level and at Santa Monica UCLA Medical Center in the Auditorium.
- Appointments: Please make an appointment using your myUCLAHealth account. If you do not have a myUCLAHealth account, please call myUCLAHealth technical support at 855-364-7052 for an activation link or text. Please do not sign up for an account on the website. You do not need to be a UCLA Health patient to get an account.
- Other opportunities to receive the booster: You can schedule an appointment through the California MyTurn portal, through Los Angeles County or at a local pharmacy.
- Safekeeping booster vaccination card: As a reminder, if you get your booster vaccine outside of UCLA Health, please retain a copy of your vaccination card for your personal recordkeeping.
A booster dose is not yet authorized or available to people who received the two-dose Moderna vaccine or the single-dose Johnson & Johnson vaccine, as there must be a separate review of data by the FDA for those vaccines. We will let you know when there is updated guidance.
At this time, COVID-19 vaccine boosters are not required for initial compliance with the UC COVID-19 vaccination policy.
We thank you for your continued efforts to help keep our campus and communities healthy and safe.
Sincerely,
Michael J. Beck
Administrative Vice Chancellor
Co-chair, COVID-19 Response and Recovery Task Force
Megan McEvoy
Professor, Institute for Society and Genetics,
Department of Microbiology, Immunology and Molecular Genetics
Co-chair, COVID-19 Response and Recovery Task Force